These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8172207)

  • 1. Clinical documentation of end-stage renal disease due to hypertension.
    Schlessinger SD; Tankersley MR; Curtis JJ
    Am J Kidney Dis; 1994 May; 23(5):655-60. PubMed ID: 8172207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
    BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure.
    Lopes AA
    Adv Ren Replace Ther; 2004 Jan; 11(1):14-23. PubMed ID: 14730535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis.
    Zarif L; Covic A; Iyengar S; Sehgal AR; Sedor JR; Schelling JR
    Nephrol Dial Transplant; 2000 Nov; 15(11):1801-7. PubMed ID: 11071968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does essential hypertension cause end-stage renal disease?
    Weisstuch JM; Dworkin LD
    Kidney Int Suppl; 1992 May; 36():S33-7. PubMed ID: 1614065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
    Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria.
    Obialo CI; Hewan-Lowe K
    J Natl Med Assoc; 1998 Nov; 90(11):649-55. PubMed ID: 9828579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension.
    Lopes AA; Hornbuckle K; James SA; Port FK
    Am J Kidney Dis; 1994 Oct; 24(4):554-60. PubMed ID: 7942809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical correlates of hypertensive end-stage renal disease.
    Bleyer AJ; Chen R; D'Agostino RB; Appel RG
    Am J Kidney Dis; 1998 Jan; 31(1):28-34. PubMed ID: 9428448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.
    Liang S; Le W; Liang D; Chen H; Xu F; Chen H; Liu Z; Zeng C
    BMC Nephrol; 2016 Apr; 17():42. PubMed ID: 27066888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality of blacks and whites with end-stage renal disease attributed to hypertension.
    Am J Kidney Dis; 1992 Nov; 20(5 Suppl 2):27-31. PubMed ID: 1442772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race, socioeconomic status, and the development of end-stage renal disease.
    Byrne C; Nedelman J; Luke RG
    Am J Kidney Dis; 1994 Jan; 23(1):16-22. PubMed ID: 8285192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension and kidney disease: a deadly connection.
    Barri YM
    Curr Hypertens Rep; 2008 Feb; 10(1):39-45. PubMed ID: 18367025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors.
    Li S; McAlpine DD; Liu J; Li S; Collins AJ
    Adv Ren Replace Ther; 2004 Jan; 11(1):5-13. PubMed ID: 14730534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertensive end-stage renal disease in blacks: the role of end-stage renal disease surveillance.
    McClellan W
    Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):25-30. PubMed ID: 8465832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence.
    August P; Leventhal B; Suthanthiran M
    Curr Hypertens Rep; 2000 Apr; 2(2):184-91. PubMed ID: 10981147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from chronic renal diseases in African Americans: treatment implications.
    Agodoa L
    Ethn Dis; 2003; 13(2 Suppl 2):S118-24. PubMed ID: 13677426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).
    Grams ME; Li L; Greene TH; Tin A; Sang Y; Kao WH; Lipkowitz MS; Wright JT; Chang AR; Astor BC; Appel LJ
    Am J Kidney Dis; 2015 Mar; 65(3):394-402. PubMed ID: 25441435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of hypertensive end-stage renal disease: effect of patient's race.
    Perneger TV; Whelton PK; Klag MJ; Rossiter KA
    Am J Epidemiol; 1995 Jan; 141(1):10-5. PubMed ID: 7801960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
    Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    Arch Intern Med; 1991 Jul; 151(7):1359-64. PubMed ID: 2064486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.